 |
 |
ugichem is focused on the development of novel gene silencing drugs that have the unique properties of good cell membrane penetration and efficacy even in mitochondria. www.ugichem.com |
|
||
 |
MaRVis Technologies GmbH develops a platform technology for magnetic resonance compatible and visible medical devices devoid of metal cores as being used in currently marketed guidewires, catheters, etc. for X-ray guided interventional procedures. These devices will be used in MR-guided interventional procedures and thus eliminate X-ray and contrast agent related risks from patients and physicians.
www.marvistech.com |
|
|
||
 |
Adriacell SRL is developing a new generation of biopharmaceuticals for the therapy of cancer patients, the CROMOC compound class., which are fusion proteins of potent active principles combined with broad range molecular targeting strategies. CROMOC compounds are designed to extend cancer treatment options beyond current antibody therapies.
www.adriacell.com |
|
|
||
 |
MagnaMedics GmbH engineers and produces magnetic nano- and microparticles that are used in diagnostics for determination of biomarkers in body fluids.
MagnaMedics also develops drug delivery tools and enables medical devices for imaging in MRI suing its MagnaFy technology. |
|
|
||
 |
APEPTICO identifies and develops synthetic peptides for the therapy of chronic and life-threatening diseases. APEPTICO's peptide drug molecules are based on comparable structural elements of human proteins and biopharmaceuticals. APEPTICO's drug molecule AP301 undergoes preclinical development for the treatment of pulmonary oedema in acute lung injury.
www.apeptico.com |
|
|
|
|
 |
|
Nano4Imaging develops and produces contrast agents and devices that can be used for in-vivo imaging of implants, transplants and minimal invasive devices such as catheters and guidewires in medical interventions and therapy. The focus of its patented technologies is to enable to use of magnetic resonance imaging (MRI), which has excellent imaging properties in soft-tissues and does not impose radiation, in clinical interventions. |
|